Back to search

Article

Impact of Lipoprotein (a) on Residual Cardiovascular Risk after an Acute Coronary Syndrome

2026-02-05

Abstract excerpt

Reducing residual cardiovascular risk following an acute coronary syndrome (ACS) remains a major unmet clinical need. Despite substantial advances in lipid-lowering therapies, the risk of recurrent major adverse cardiovascular events (MACE) after ACS remains high, with an estimated incidence of approximately 33.4% at 5 years. Residual cardiovascular risk is driven by multiple mechanisms, including persistent infla...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
f8b3260d-910f-5893-a1bc-64fc330d7b5e
DOI
10.20944/preprints202602.0291.v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Impact of Lipoprotein (a) on Residual Cardiovascular Risk after an Acute Coronary SyndromeDOI 10.20944/preprints202602.0291.v1
Select a neighboring publication to make it the new centre.